• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Parsaclisib HCl

CAS No. 1995889-48-9

Parsaclisib HCl ( INCB50465 HCl | INCB-50465 | INCB 50465 | INCB050465 HCl | INCB-050465 | INCB 050465 )

产品货号. M23900 CAS No. 1995889-48-9

Parsaclisib HCl 是一种具有抗肿瘤活性的选择性 PI3Kδ 抑制剂。 Parsaclisib 表现出有效的活性,IC50 值范围为 0.2 至 2 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥2624 有现货
50MG ¥13041 有现货
100MG ¥20817 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Parsaclisib HCl
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Parsaclisib HCl 是一种具有抗肿瘤活性的选择性 PI3Kδ 抑制剂。 Parsaclisib 表现出有效的活性,IC50 值范围为 0.2 至 2 nM。
  • 产品描述
    Parsaclisib HCl is a selectve PI3Kδ inhibitor with antitumor activity. Parsaclisib demonstrates potent activity with IC50 values ranging from 0.2 to 2 nM.
  • 体外实验
    Parsaclisib (0.1-3000 nM; 4 d) inhibits proliferation of MCL and DLBCL cell lines.Parsaclisib (0.1-1000 nM; 2 h) inhibits anti-IgM-induced pAKT (Ser473) in the Ramos Burkitt’s lymphoma cell line, with an IC50 of 1 nM.Parsaclisib inhibits the proliferation of human, dog, rat, and mouse primary B cells after activation of these receptors, with IC50s ranging from 0.2 to 1.7 nM. Cell Proliferation AssayCell Line:Jeko-1, Mino, JVM2, Rec-1, Pfeiffer, SU-DHL-5, SU-DHL-6, WSU-NHL, SU-DHL-4, SU-DHL-8, and WILL-2 cells Concentration:0.1-3000 nM Incubation Time:4 days Result:Resulted in a maximal inhibition of 70-90%, with IC50s of ≤10 nM in the four MCL cell lines.Pfeiffer, SU-DHL-5, SU-DHL-6, and WSU-NHL were highly sensitive, with IC50s from 2 to 8 nM.
  • 体内实验
    Parsaclisib (10 mg/kg; oral gavage twice daily for 7-19 days) inhibits tumor growth in the BALB/c mice bearing the A20 murine lymphoma cells.Parsaclisib (0.1-10 mg/kg; p.o. twice daily) slows Pfeiffer xenograft tumor growth in a dose-dependent manner. And Parsaclisib was well tolerated.Parsaclisib (0.5-1 mg/kg; a single p.o.) inhibits pAKT (Ser473) in Pfeiffer subcutaneous mouse xenograft models. Animal Model:Female BALB/c mice (5-9 weeks) were inoculated with A20 cells Dosage:10 mg/kg Administration:Oral gavage twice daily for 7-19 days Result:Resulted in significant tumor growth inhibition (TGI).Reduced the percentage of Tregs (CD4+CD25+FOXP3+) in tumors and spleens.Increased the ratio of CD4+ and CD8+ T cells to Tregs in spleens and tumors.Decreased the number of CD4+CD44 high and CD8+CD44 high T cells in both spleens and tumors.
  • 同义词
    INCB50465 HCl | INCB-50465 | INCB 50465 | INCB050465 HCl | INCB-050465 | INCB 050465
  • 通路
    PI3K/Akt/mTOR signaling
  • 靶点
    PI3K
  • 受体
    PI3Kδ
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1995889-48-9
  • 分子量
    469.34
  • 分子式
    C20H23Cl2FN6O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO:90 mg/mL(191.76 mM);Water:Insoluble
  • SMILES
    O=C1NC[C@@H](C2=C(F)C(Cl)=CC([C@@H](N3N=C(C)C4=C(N)N=CN=C43)C)=C2OCC)C1.[H]Cl
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Shin N, et al. Abstract 2671: INCB050465, a novel PI3Kδ inhibitor, synergizes with PIM protein kinase inhibition to cause tumor regression in a model of DLBCL. Cancer Research. 2015, Aug. 75(15)
产品手册
关联产品
  • Tectorigenin

    鸢尾皂甙元是一种 O-甲基化异黄酮。鸢尾皂甙元促进成骨细胞分化和体内骨愈合。

  • PI-3065

    PI3K p110δ 的有效抑制剂,IC50/Ki 值分别为 5/1.5 nM。

  • NVP-BKM120

    NVP-BKM120(BKM-120,Buparlisib)是一种有效的、选择性的、口服生物可利用的 I 类 PI3K 亚型抑制剂。